Humana Reports Q3 Revenue Growth Despite CMS Funding Headwinds
What happened
Humana reported third-quarter revenue of $41.155 billion, marking a 26.05% increase. The company also raised its full-year adjusted EPS guidance to at least $9.50. However, the company noted that utilization costs climbed and Star Ratings were cut, which initially impacted 2026 guidance.
From 247wallst.com
Why it matters
Humana's business relies heavily on CMS benchmark funding and Star Ratings quality bonuses for its Medicare Advantage plans. The reported revenue growth and guidance raise suggest operational resilience, but rising utilization costs and regulatory changes pose financial pressure on the insurer.
From 247wallst.com
Who's involved
Who could feel it
Possible knock-on effectsThese are possibilities Brind reasoned out, not predictions, and not advice. Most are not stated in any report.
- CMSSpeculative
Its benchmark funding models could affect the revenue of major Medicare Advantage carriers.
- HumanaSpeculative
The company might face increased costs due to rising utilization rates.
- AetnaSpeculative
The parent company might see changes in investment returns due to the insurer's financial pressures.
Keep exploring
The entities involved
-
Humana
American managed health care company
-
Medicare
US federal health insurance
-
CMS
International law firm
Related events
- CMS manages Medicare plans for seniors residing in Long Island.
- CMS is actively involved in the operational oversight of Medicare Advantage plans, including determining enrollee health statuses and auditing carriers like Humana and UnitedHealthcare for overcharging.
- UnitedHealthcare offers Medicare Rx plans while CMS provides 2027 plan files for projections.